ClinicalTrials.Veeva

Menu

The Predictive Value of Progesterone (PFRET)

G

Ghent University Hospital (UZ)

Status

Active, not recruiting

Conditions

Subfertility

Study type

Observational

Funder types

Other

Identifiers

NCT05876234
ONZ-2023-0223

Details and patient eligibility

About

To evaluate a 5 ng/ml serum progesterone (P4) threshold policy for the addition of subcutaneous (SC) P4 in artificially prepared frozen embryo transfer cycles treated with vaginal P4. We assess whether the addition of SC P4 rescues cycles with serum P4 <5 ng/ml and we study the impact of not supplementing cycles with serum P4 >5 ng/ml by comparing them with serum P4 cycles above the conventionally proposed cut-off of 10 ng/ml.

Enrollment

3,000 estimated patients

Sex

Female

Ages

18 to 47 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

  • Embryo transfer between March 1st 2021 and March 31st 2023
  • Determination of progesterone on the day of embryo transfer

Trial contacts and locations

1

Loading...

Central trial contact

Sara Somers, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems